Evidence map›Paper›PMID 38205056›Full record

ArticleFood technology and biotechnology2023

Total Antioxidant Potential, Total Phenolic Profile and Cytotoxic Activity Against Brain Cancer: Melocan and Galdirik

Diaa Al Yassine, Nourhane El Massri, Gunnur Demircan, Gulay Bulut, Demet Akin, Zeynep Tacer-Caba

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food technology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Alteration of mMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Diaa Al YassineGraduate School of Engineering, Bioengineering Program, Bahçeşehir University, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-6165-6722
Nourhane El MassriGraduate School of Engineering, Bioengineering Program, Bahçeşehir University, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-3307-3508
Gunnur DemircanDepartment of Medical Biology and Genetics, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7355-9065
Gulay BulutFaculty of Medicine, Department of Medical Biology, Karabuk University, Karabuk, Turkey.ORCID https://orcid.org/0000-0003-0446-4841
Demet AkinDepartment of Pharmacology, Bahçeşehir University School of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-9972-5049
Zeynep Tacer-CabaDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Bahçeşehir University, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-2811-6462
Bahçeşehir University · TRIstanbul Bilim University · TRKarabük University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research background: Brain cancer is known to be one of the most difficult types of cancer to cure. It has a serious impact on the lives of diagnosed people due to the insufficient treatment options and their side effects. The search for new alternative treatments is therefore ongoing. Melocan ( Experimental approach: The aim of this study is to determine the antioxidant and cytotoxic activity of Results and conclusions: According to the results, the water extracts of Novelty and scientific contribution: This is the first study that aims to evaluate the potential cytotoxic activity of two local Turkish plants,

Indexed as

brain cancerC6 glioblastomaSmilax excelsa L.Trachystemon orientalis

Identifiers

PMID38205056
PMCPMC10775792
OpenAlexW4389009756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.